Last Funding Type: Series C
Funding Status: IPO
Headquarters: Hayward, California, United States
Founded Date: 2015
Investor Type: N/A
Investment Stage: N/A
Total Funding: $226.7M
Technology: Anti-infective Drugs
Employee Number: 101-250
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Investors Number: 17
Industry: PharmTech